Global Peptide-based Drug Market Growth (Status and Outlook) 2022-2028
- LP 4891107
- 100 Pages
- March 2022
- Pharmaceuticals
The United States Peptide-based Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Peptide-based Drug market, reaching US$ million by the year 2028. As for the Europe Peptide-based Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Peptide-based Drug players cover Sanofi, Teva, Novo Nordisk, and Takeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide-based Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injection
Oral
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Metabolic Disorders
Central Nervous System
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptide-based Drug Market Size 2017-2028
2.1.2 Peptide-based Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Peptide-based Drug Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 Other
2.3 Peptide-based Drug Market Size by Type
2.3.1 Peptide-based Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Peptide-based Drug Market Size Market Share by Type (2017-2022)
2.4 Peptide-based Drug Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Peptide-based Drug Market Size by Application
2.5.1 Peptide-based Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Peptide-based Drug Market Size Market Share by Application (2017-2022)
3 Peptide-based Drug Market Size by Player
3.1 Peptide-based Drug Market Size Market Share by Players
3.1.1 Global Peptide-based Drug Revenue by Players (2020-2022)
3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2020-2022)
3.2 Global Peptide-based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peptide-based Drug by Regions
4.1 Peptide-based Drug Market Size by Regions (2017-2022)
4.2 Americas Peptide-based Drug Market Size Growth (2017-2022)
4.3 APAC Peptide-based Drug Market Size Growth (2017-2022)
4.4 Europe Peptide-based Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Peptide-based Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Peptide-based Drug Market Size by Country (2017-2022)
5.2 Americas Peptide-based Drug Market Size by Type (2017-2022)
5.3 Americas Peptide-based Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide-based Drug Market Size by Region (2017-2022)
6.2 APAC Peptide-based Drug Market Size by Type (2017-2022)
6.3 APAC Peptide-based Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peptide-based Drug by Country (2017-2022)
7.2 Europe Peptide-based Drug Market Size by Type (2017-2022)
7.3 Europe Peptide-based Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptide-based Drug by Region (2017-2022)
8.2 Middle East & Africa Peptide-based Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Peptide-based Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Peptide-based Drug Market Forecast
10.1 Global Peptide-based Drug Forecast by Regions (2023-2028)
10.1.1 Global Peptide-based Drug Forecast by Regions (2023-2028)
10.1.2 Americas Peptide-based Drug Forecast
10.1.3 APAC Peptide-based Drug Forecast
10.1.4 Europe Peptide-based Drug Forecast
10.1.5 Middle East & Africa Peptide-based Drug Forecast
10.2 Americas Peptide-based Drug Forecast by Country (2023-2028)
10.2.1 United States Peptide-based Drug Market Forecast
10.2.2 Canada Peptide-based Drug Market Forecast
10.2.3 Mexico Peptide-based Drug Market Forecast
10.2.4 Brazil Peptide-based Drug Market Forecast
10.3 APAC Peptide-based Drug Forecast by Region (2023-2028)
10.3.1 China Peptide-based Drug Market Forecast
10.3.2 Japan Peptide-based Drug Market Forecast
10.3.3 Korea Peptide-based Drug Market Forecast
10.3.4 Southeast Asia Peptide-based Drug Market Forecast
10.3.5 India Peptide-based Drug Market Forecast
10.3.6 Australia Peptide-based Drug Market Forecast
10.4 Europe Peptide-based Drug Forecast by Country (2023-2028)
10.4.1 Germany Peptide-based Drug Market Forecast
10.4.2 France Peptide-based Drug Market Forecast
10.4.3 UK Peptide-based Drug Market Forecast
10.4.4 Italy Peptide-based Drug Market Forecast
10.4.5 Russia Peptide-based Drug Market Forecast
10.5 Middle East & Africa Peptide-based Drug Forecast by Region (2023-2028)
10.5.1 Egypt Peptide-based Drug Market Forecast
10.5.2 South Africa Peptide-based Drug Market Forecast
10.5.3 Israel Peptide-based Drug Market Forecast
10.5.4 Turkey Peptide-based Drug Market Forecast
10.5.5 GCC Countries Peptide-based Drug Market Forecast
10.6 Global Peptide-based Drug Forecast by Type (2023-2028)
10.7 Global Peptide-based Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Peptide-based Drug Product Offered
11.1.3 Sanofi Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Peptide-based Drug Product Offered
11.2.3 Teva Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Peptide-based Drug Product Offered
11.3.3 Novo Nordisk Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Peptide-based Drug Product Offered
11.4.3 Takeda Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Peptide-based Drug Product Offered
11.5.3 Eli Lilly Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Peptide-based Drug Product Offered
11.6.3 AstraZeneca Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Peptide-based Drug Product Offered
11.7.3 Novartis Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Peptide-based Drug Product Offered
11.8.3 AbbVie Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Peptide-based Drug Product Offered
11.9.3 Ipsen Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Peptide-based Drug Product Offered
11.10.3 Ferring Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Peptide-based Drug Product Offered
11.11.3 Merck Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Peptide-based Drug Product Offered
11.12.3 The Medicines Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Peptide-based Drug Product Offered
11.13.3 J & J Peptide-based Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments
12 Research Findings and Conclusion
Table 1. Peptide-based Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Injection
Table 3. Major Players of Oral
Table 4. Major Players of Other
Table 5. Peptide-based Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Peptide-based Drug Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Peptide-based Drug Market Size Market Share by Type (2017-2022)
Table 8. Peptide-based Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Peptide-based Drug Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Peptide-based Drug Market Size Market Share by Application (2017-2022)
Table 11. Global Peptide-based Drug Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Peptide-based Drug Revenue Market Share by Player (2020-2022)
Table 13. Peptide-based Drug Key Players Head office and Products Offered
Table 14. Peptide-based Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peptide-based Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Peptide-based Drug Market Size Market Share by Regions (2017-2022)
Table 19. Americas Peptide-based Drug Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Peptide-based Drug Market Size Market Share by Country (2017-2022)
Table 21. Americas Peptide-based Drug Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Peptide-based Drug Market Size Market Share by Type (2017-2022)
Table 23. Americas Peptide-based Drug Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Peptide-based Drug Market Size Market Share by Application (2017-2022)
Table 25. APAC Peptide-based Drug Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Peptide-based Drug Market Size Market Share by Region (2017-2022)
Table 27. APAC Peptide-based Drug Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Peptide-based Drug Market Size Market Share by Type (2017-2022)
Table 29. APAC Peptide-based Drug Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Peptide-based Drug Market Size Market Share by Application (2017-2022)
Table 31. Europe Peptide-based Drug Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Peptide-based Drug Market Size Market Share by Country (2017-2022)
Table 33. Europe Peptide-based Drug Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Peptide-based Drug Market Size Market Share by Type (2017-2022)
Table 35. Europe Peptide-based Drug Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Peptide-based Drug Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Peptide-based Drug Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Peptide-based Drug Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Peptide-based Drug Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Peptide-based Drug Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Peptide-based Drug Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Peptide-based Drug Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Peptide-based Drug
Table 44. Key Market Challenges & Risks of Peptide-based Drug
Table 45. Key Industry Trends of Peptide-based Drug
Table 46. Global Peptide-based Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Peptide-based Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Peptide-based Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Peptide-based Drug Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Peptide-based Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Peptide-based Drug Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sanofi Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 53. Sanofi Peptide-based Drug Product Offered
Table 54. Sanofi Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. Teva Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 58. Teva Peptide-based Drug Product Offered
Table 59. Teva Main Business
Table 60. Teva Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Teva Latest Developments
Table 62. Novo Nordisk Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 63. Novo Nordisk Peptide-based Drug Product Offered
Table 64. Novo Nordisk Main Business
Table 65. Novo Nordisk Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Novo Nordisk Latest Developments
Table 67. Takeda Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 68. Takeda Peptide-based Drug Product Offered
Table 69. Takeda Main Business
Table 70. Takeda Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Takeda Latest Developments
Table 72. Eli Lilly Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 73. Eli Lilly Peptide-based Drug Product Offered
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Eli Lilly Latest Developments
Table 77. AstraZeneca Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 78. AstraZeneca Peptide-based Drug Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. AstraZeneca Latest Developments
Table 82. Novartis Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 83. Novartis Peptide-based Drug Product Offered
Table 84. Novartis Main Business
Table 85. Novartis Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Novartis Latest Developments
Table 87. AbbVie Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 88. AbbVie Peptide-based Drug Product Offered
Table 89. AbbVie Main Business
Table 90. AbbVie Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. AbbVie Latest Developments
Table 92. Ipsen Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 93. Ipsen Peptide-based Drug Product Offered
Table 94. Ipsen Main Business
Table 95. Ipsen Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Ipsen Latest Developments
Table 97. Ferring Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 98. Ferring Peptide-based Drug Product Offered
Table 99. Ferring Main Business
Table 100. Ferring Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Ferring Latest Developments
Table 102. Merck Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 103. Merck Peptide-based Drug Product Offered
Table 104. Merck Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. The Medicines Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 108. The Medicines Peptide-based Drug Product Offered
Table 109. The Medicines Main Business
Table 110. The Medicines Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. The Medicines Latest Developments
Table 112. J & J Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 113. J & J Peptide-based Drug Product Offered
Table 114. J & J Main Business
Table 115. J & J Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. J & J Latest Developments
List of Figures
Figure 1. Peptide-based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide-based Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Peptide-based Drug Market Size Market Share by Type in 2021
Figure 7. Peptide-based Drug in Cancer
Figure 8. Global Peptide-based Drug Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Peptide-based Drug in Metabolic Disorders
Figure 10. Global Peptide-based Drug Market: Metabolic Disorders (2017-2022) & ($ Millions)
Figure 11. Peptide-based Drug in Central Nervous System
Figure 12. Global Peptide-based Drug Market: Central Nervous System (2017-2022) & ($ Millions)
Figure 13. Peptide-based Drug in Other
Figure 14. Global Peptide-based Drug Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Peptide-based Drug Market Size Market Share by Application in 2021
Figure 16. Global Peptide-based Drug Revenue Market Share by Player in 2021
Figure 17. Global Peptide-based Drug Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Peptide-based Drug Market Size 2017-2022 ($ Millions)
Figure 19. APAC Peptide-based Drug Market Size 2017-2022 ($ Millions)
Figure 20. Europe Peptide-based Drug Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Peptide-based Drug Market Size 2017-2022 ($ Millions)
Figure 22. Americas Peptide-based Drug Value Market Share by Country in 2021
Figure 23. Americas Peptide-based Drug Consumption Market Share by Type in 2021
Figure 24. Americas Peptide-based Drug Market Size Market Share by Application in 2021
Figure 25. United States Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Peptide-based Drug Market Size Market Share by Region in 2021
Figure 30. APAC Peptide-based Drug Market Size Market Share by Application in 2021
Figure 31. China Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Peptide-based Drug Market Size Market Share by Country in 2021
Figure 38. Europe Peptide-based Drug Market Size Market Share by Type in 2021
Figure 39. Europe Peptide-based Drug Market Size Market Share by Application in 2021
Figure 40. Germany Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Peptide-based Drug Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Peptide-based Drug Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Peptide-based Drug Market Size Market Share by Application in 2021
Figure 48. Egypt Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Peptide-based Drug Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 54. APAC Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 55. Europe Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 57. United States Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 58. Canada Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 61. China Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 62. Japan Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 63. Korea Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 65. India Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 66. Australia Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 67. Germany Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 68. France Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 69. UK Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 70. Italy Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 71. Russia Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 72. Spain Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 75. Israel Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Peptide-based Drug Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Peptide-based Drug Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
